Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.8K Hold
16,169
0.01% 764
2026
Q1
$47.2K Sell
16,169
-64,817
-80% -$185K 0.01% 725
2025
Q4
$200K Buy
+80,986
New +$193K 0.08% 559
2025
Q2
Sell
-175,977
Closed -$410K 592
2025
Q1
$410K Buy
175,977
+26,023
+17% +$52.1K 0.19% 180
2024
Q4
$277K Buy
+149,954
New +$332K 0.12% 423
2024
Q2
Sell
-9,922
Closed -$24.6K 1360
2024
Q1
$24.6K Sell
9,922
-22,145
-69% -$57.7K 0.02% 1028
2023
Q4
$89.8K Buy
+32,067
New +$86.6K 0.09% 434

Other funds holding ABEV

EntryPoint Capital's ABEV Position: Q2 2026 in Review

EntryPoint Capital held its Ambev (ABEV) position steady in Q2 2026 at 16,169 shares worth $50.8K. The position accounts for 0.01% of the portfolio, ranked #764.

EntryPoint Capital first reported a position in ABEV in Q4 2023 and has held it in 7 quarters since. The position peaked at $410K in Q1 2025. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • EntryPoint Capital held 16,169 shares of Ambev worth $50.8K as of Q2 2026.
  • EntryPoint Capital left its Ambev share count unchanged in Q2 2026.
  • Ambev made up 0.01% of EntryPoint Capital's portfolio in Q2 2026, its #764 holding.
  • EntryPoint Capital first reported a position in Ambev in Q4 2023 and has held it in 7 quarters since.
  • EntryPoint Capital's Ambev position peaked at $410K in Q1 2025.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.